PRO1184 for Advanced Solid Tumors

Conditions:   Ovarian Cancer;   Primary Peritoneal Carcinoma;   Fallopian Tube Cancer;   Endometrial Cancer;   Non-small Cell Lung Cancer;   Mesothelioma;   Triple Negative Breast Cancer;   HER2-negative Breast Cancer;   Hormone Receptor-positive Breast Cancer Intervention:   Drug: PRO1184 Sponsor:   ProfoundBio US Co. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials